ETF Holdings Breakdown of INCY
| Stock Name | Incyte Corporation |
| Ticker | INCY(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US45337C1027 |
| LEI | 549300Z4WN6JVZ3T4680 |
News associated with INCY
- Incyte Earnings Preview: What to Expect
- Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth. - 2025-04-16 17:41:38
- Incyte Earnings Preview: What to Expect
- Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth. - 2025-04-16 13:55:44
- Franklin Resources Inc. Acquires 143,059 Shares of Incyte Co. (NASDAQ:INCY)
- Franklin Resources Inc. lifted its stake in Incyte Co. (NASDAQ:INCY – Free Report) by 70.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 344,777 shares of the biopharmaceutical company’s stock after purchasing an additional 143,059 shares during the period. Franklin Resources Inc.’s holdings in Incyte were worth $23,814,000 as of its most recent […] - 2025-04-07 08:40:56
- Incyte Stock: Is INCY Outperforming the Health Care Sector?
- Incyte has outperformed the health care sector over the past year, and analysts are moderately optimistic about the stock’s prospects. - 2025-04-01 15:55:45
- Incyte Co. (NASDAQ:INCY) Shares Bought by Corient Private Wealth LLC
- Corient Private Wealth LLC lifted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 3.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 28,577 shares of the biopharmaceutical company’s stock after buying an additional 979 shares during the period. Corient Private Wealth LLC’s holdings […] - 2025-03-25 08:36:52
- Incyte (NASDAQ:INCY) Rating Lowered to “Market Perform” at William Blair
- Incyte (NASDAQ:INCY – Get Free Report) was downgraded by William Blair from an “outperform” rating to a “market perform” rating in a note issued to investors on Tuesday, Marketbeat.com reports. William Blair also issued estimates for Incyte’s FY2025 earnings at $4.21 EPS. Several other brokerages have also recently issued reports on INCY. Wells Fargo & […] - 2025-03-20 06:28:53
- Truist Financial Cuts Incyte (NASDAQ:INCY) Price Target to $72.00
- Incyte (NASDAQ:INCY – Free Report) had its price target reduced by Truist Financial from $74.00 to $72.00 in a report issued on Tuesday,Benzinga reports. They currently have a hold rating on the biopharmaceutical company’s stock. INCY has been the subject of a number of other reports. Guggenheim lowered shares of Incyte from a “buy” rating […] - 2025-03-19 07:48:48
- Incyte (NASDAQ:INCY) Stock Rating Lowered by Guggenheim
- Guggenheim lowered shares of Incyte (NASDAQ:INCY – Free Report) from a buy rating to a neutral rating in a report issued on Tuesday, Marketbeat Ratings reports. They currently have $92.00 price objective on the biopharmaceutical company’s stock. Several other brokerages have also recently issued reports on INCY. Citigroup reduced their price target on shares of […] - 2025-03-19 06:47:05
- Bank of New York Mellon Corp Increases Holdings in Incyte Co. (NASDAQ:INCY)
- Bank of New York Mellon Corp boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 7.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,127,515 shares of the biopharmaceutical company’s stock after buying an additional […] - 2025-03-04 09:51:06
- IFP Advisors Inc Sells 372 Shares of Incyte Co. (NASDAQ:INCY)
- IFP Advisors Inc trimmed its position in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 12.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,532 shares of the biopharmaceutical company’s stock after selling 372 shares during the period. IFP Advisors Inc’s holdings […] - 2025-03-04 09:14:52
- New York State Common Retirement Fund Trims Holdings in Incyte Co. (NASDAQ:INCY)
- New York State Common Retirement Fund cut its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 6.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 80,641 shares of the biopharmaceutical company’s stock after selling 5,500 shares during the period. New […] - 2025-02-28 09:04:57
- Principal Financial Group Inc. Sells 8,222 Shares of Incyte Co. (NASDAQ:INCY)
- Principal Financial Group Inc. reduced its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 212,528 shares of the biopharmaceutical company’s stock after selling 8,222 shares during the period. Principal Financial Group […] - 2025-02-27 08:30:52
- Sanctuary Advisors LLC Acquires 6,274 Shares of Incyte Co. (NASDAQ:INCY)
- Sanctuary Advisors LLC increased its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 29.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 27,330 shares of the biopharmaceutical company’s stock after buying an additional 6,274 shares during the quarter. […] - 2025-02-24 08:51:05
- Incyte Co. (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
- Vontobel Holding Ltd. reduced its stake in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 23.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 9,467 shares of the biopharmaceutical company’s stock after selling 2,944 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $654,000 at the end of the […] - 2025-02-20 09:48:52
- Asset Management One Co. Ltd. Purchases 397 Shares of Incyte Co. (NASDAQ:INCY)
- Asset Management One Co. Ltd. boosted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 89,284 shares of the biopharmaceutical company’s stock after acquiring an additional 397 shares during the quarter. Asset Management […] - 2025-02-19 10:09:02
- Are Wall Street Analysts Bullish on Incyte Stock?
- Incyte has continued to observe strong demand for Jakafi and Opzelura, leading to robust growth in sales, and analysts remain bullish on the stock’s prospects. - 2025-02-18 14:26:19
- New York State Teachers Retirement System Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY)
- New York State Teachers Retirement System reduced its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 173,577 shares of the biopharmaceutical company’s stock after selling 318 shares during the period. New York State […] - 2025-02-18 09:29:11
- Chevy Chase Trust Holdings LLC Sells 1,802 Shares of Incyte Co. (NASDAQ:INCY)
- Chevy Chase Trust Holdings LLC lowered its holdings in Incyte Co. (NASDAQ:INCY – Free Report) by 2.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 83,907 shares of the biopharmaceutical company’s stock after selling 1,802 shares during the period. Chevy Chase Trust Holdings […] - 2025-02-18 09:28:57
- Yousif Capital Management LLC Decreases Position in Incyte Co. (NASDAQ:INCY)
- Yousif Capital Management LLC trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 5.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,109 shares of the biopharmaceutical company’s stock after selling 932 shares during the […] - 2025-02-14 08:24:54
- Incyte (NASDAQ:INCY) Lowered to Buy Rating by StockNews.com
- Incyte (NASDAQ:INCY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Wednesday. A number of other equities analysts have also recently issued reports on the company. Wells Fargo & Company lifted their target price on Incyte from […] - 2025-02-12 07:12:43
- Incyte (NASDAQ:INCY) Shares Down 8.5% After Earnings Miss
- Incyte Co. (NASDAQ:INCY – Get Free Report)’s share price dropped 8.5% during mid-day trading on Monday following a dissappointing earnings announcement. The company traded as low as $68.18 and last traded at $67.85. Approximately 470,521 shares changed hands during trading, a decline of 66% from the average daily volume of 1,386,096 shares. The stock had […] - 2025-02-12 06:14:56
- Incyte Co. (NASDAQ:INCY) Shares Purchased by Mirae Asset Global Investments Co. Ltd.
- Mirae Asset Global Investments Co. Ltd. raised its position in Incyte Co. (NASDAQ:INCY – Free Report) by 12.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 23,467 shares of the biopharmaceutical company’s stock after acquiring an additional 2,532 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Incyte were worth […] - 2025-02-11 08:44:52
- Incyte Co. (NASDAQ:INCY) Shares Bought by Blue Trust Inc.
- Blue Trust Inc. grew its position in Incyte Co. (NASDAQ:INCY – Free Report) by 124.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 593 shares of the biopharmaceutical company’s stock after acquiring an additional 329 shares during the period. Blue Trust Inc.’s holdings in […] - 2025-02-10 22:21:01
- abrdn plc Has $3.87 Million Stock Holdings in Incyte Co. (NASDAQ:INCY)
- abrdn plc decreased its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 14.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 56,434 shares of the biopharmaceutical company’s stock after selling 9,804 shares during the quarter. abrdn plc’s […] - 2025-02-10 18:43:00
- Incyte Q4 24 Earnings Conference Call AT 8:00 AM ET
- (RTTNews) - Incyte Corporation (INCY) will host a conference call at 8:00 AM ET on February 10, 2025, to discuss Q4 24 earnings results. - 2025-02-10 12:01:11
- Mather Group LLC. Has $57,000 Position in Incyte Co. (NASDAQ:INCY)
- Mather Group LLC. raised its position in Incyte Co. (NASDAQ:INCY – Free Report) by 26.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 828 shares of the biopharmaceutical company’s stock after purchasing an additional 173 shares during the quarter. Mather Group LLC.’s holdings in Incyte were worth $57,000 as of its most recent filing […] - 2025-02-08 08:44:50
- Trust Point Inc. Has $227,000 Stake in Incyte Co. (NASDAQ:INCY)
- Trust Point Inc. lifted its stake in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 5.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,282 shares of the biopharmaceutical company’s stock after acquiring an additional 156 shares during the period. Trust Point Inc.’s […] - 2025-02-07 10:01:00
- Greenleaf Trust Boosts Holdings in Incyte Co. (NASDAQ:INCY)
- Greenleaf Trust increased its position in Incyte Co. (NASDAQ:INCY – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,066 shares of the biopharmaceutical company’s stock after purchasing an additional 217 shares during the period. Greenleaf […] - 2025-02-06 08:44:54
- Incyte (NASDAQ:INCY) Rating Increased to Strong-Buy at StockNews.com
- Incyte (NASDAQ:INCY – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Tuesday. INCY has been the subject of several other reports. Cantor Fitzgerald reissued a “neutral” rating on shares of Incyte in a research note on Friday, January 10th. […] - 2025-02-06 06:50:44
- Incyte Co. (NASDAQ:INCY) Holdings Lifted by Tokio Marine Asset Management Co. Ltd.
- Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 7.1% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 6,863 shares of the biopharmaceutical company’s stock after purchasing an additional 457 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Incyte […] - 2025-02-05 09:46:58
INCY institutional holdings
The following institutional investment holdings of INCY have been identified | Date | ETF ISIN/Name | Num Shares | Book value |
Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119
Stack trace:
#0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query()
#1 {main}
thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119